CYBIN INC. current report, Q3 FY2023

Cybin Inc. Form 6-K Summary

Business context and reporting period

Cybin Inc., a Canadian foreign private issuer, filed Form 6-K for September 2023. The filing was signed on September 26, 2023, by Doug Drysdale, Chief Executive Officer. The submission identifies a news release as Exhibit 99.1, but the provided filing text does not include the release itself.

Financial and operating metrics

The provided text does not disclose revenue, profit or loss, cash flow, margins, debt, liquidity, research and development spending, cash balance, or other financial metrics.

Material changes versus the prior comparable period

The filing text does not provide financial results or operating information sufficient to identify changes versus a prior period.

Guidance, outlook, risks, and unusual items

No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. These matters may be addressed in the referenced Exhibit 99.1 news release, which is not included.

Facts investors should verify

  • Obtain and review Exhibit 99.1, the news release dated September 26, 2023.
  • Verify whether the omitted news release contains financial, clinical, financing, regulatory, or corporate developments.
  • Confirm the company’s latest cash position, financing needs, and clinical-program status from the complete filing record and subsequent disclosures.